Finance
The Boston and Tel Aviv-based company includes a predictive analytics tool which helps intervene in a person's aging trajectory.
Together the businesses have 900,000 subscribers.
The app aims to give users customised insights to help gain a holistic understanding of what impacts their overall health, mood and fitness.
This new funding brings the company's total funding pot to $135 million.
The new acquistiion is expected to help the company grow out its diagnostic capabilities.
The company's IPO included around 4.4 million shares.
This new infusion of cash brings the company's total funding to $15M.
Apostrophe is able to offer patients oral and topical acne medications.
The opening day stock prices are listed at $8.90 and the deal is expected to give Talkspace $250 million in growth capital.
The funds will be used to accelerate the expansion of its digital care platform for respiratory health.